DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Nicardipine Hydrochloride is a drug marketed by Ani Pharms Inc, Epic Pharma, Mylan, Am Regent, Exela Pharma Science, Mylan Institutional, Navinta Llc, Sun Pharma Global, West-ward Pharms Int, and Wockhardt. and is included in twelve NDAs.
The generic ingredient in NICARDIPINE HYDROCHLORIDE is nicardipine hydrochloride. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the nicardipine hydrochloride profile page.
A generic version of NICARDIPINE HYDROCHLORIDE was approved as nicardipine hydrochloride by MYLAN on July 18th, 1996.
Summary for NICARDIPINE HYDROCHLORIDE
|Suppliers / Packagers:||8|
|Bulk Api Vendors:||77|
|Formulation / Manufacturing:||see details|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for NICARDIPINE HYDROCHLORIDE|
|DailyMed Link:||NICARDIPINE HYDROCHLORIDE at DailyMed|
Recent Clinical Trials for NICARDIPINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
|Damietta University||Phase 2|
|Kafrelsheikh University||Phase 2|
|Kafrelsheikh University||Phase 3|